Retatrutide – 10 mg

Description

Retatrutide 10 mg is an investigational once-weekly injectable peptide being developed for weight management and metabolic health. It works by targeting three hormone receptors GLP-1, GIP, and glucagon to help regulate appetite, energy expenditure, and blood sugar levels. Early clinical trials have shown promising weight-loss results, but Retatrutide is not currently approved for use in the UK and is only available through authorised clinical trials. Any products marketed as Retatrutide 10 mg outside these trials should be approached with caution, as they may be unlicensed and their safety, quality, and effectiveness cannot be guaranteed.